Archives

Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer

B – Proven Leader in Neurology Drug Development, Including for Several Approved Multiple Sclerosis Therapies – – Strong Experience in Advancing Late-Stage Clinical Programs and… Login to continue reading Login…

Read MoreImmunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer

Commonwealth Fusion Systems Becomes First Fusion Company to Apply to PJM Interconnection, the Largest U.S. Wholesale Electricity Market

B The application marks the first time a fusion power plant developer has requested to join a major grid operator. Through this submission, CFS is… Login to continue reading Login…

Read MoreCommonwealth Fusion Systems Becomes First Fusion Company to Apply to PJM Interconnection, the Largest U.S. Wholesale Electricity Market

HERVolution Therapeutics Appoints Dr. László B. Tankó to Scientific Advisory Board to Strengthen Cardiometabolic Clinical Development Strategy

B Industry veteran brings 25+ years of global clinical leadership from Ferring, Novartis, NIBR, Bayer, and SixPeaks Bio to support HERVolution’s cardiometabolic pipeline Tankó’s strategic… Login to continue reading Login…

Read MoreHERVolution Therapeutics Appoints Dr. László B. Tankó to Scientific Advisory Board to Strengthen Cardiometabolic Clinical Development Strategy